What will it take to get institutional investors interested in life sciences again?

Abstract

With the European biotechnology market nearing a crisis state, companies must try to attract and maintain interest from institutional investors. In this article, a brief outline of who companies should be trying to appeal to and how these investors view the sector is followed by an assessment of the areas that management must focus on to attract investors. The problems that they must avoid to prevent disappointing investors are outlined.